Others Products Targets
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- Matrix Metalloprotease (16)
- LXR-like Receptor (6)
- Elastase (1)
- EGFR (28)
- Voltage-gated Sodium (NaV) Channel (30)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Others (6)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- Vitamin D Receptor (10)
- Progesterone Receptor (4)
- Mineralocorticoid Receptor (7)
- Pregnane X Receptor (3)
- Constitutive Androstane Receptor (5)
- Aryl Hydrocarbon Receptor (8)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Retinoic Acid-related Orphan Receptor (4)
- Rev-Erb Receptor (2)
- Estrogen and Related Receptor (33)
- Histamine H4 Receptor (12)
- Histamine H3 Receptor (22)
- Histamine H2 Receptor (10)
- Histamine H1 Receptor (17)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Adenosine A3 Receptor (8)
- Adenosine A1 Receptor (12)
- Calcitonin and Related Receptor (10)
- Androgen Receptor (11)
- Adrenergic α2 Receptor (33)
- Adrenergic α1 Receptor (22)
- Adrenergic β3 Receptor (12)
- Adrenergic β2 Receptor (6)
- Adrenergic β1 Receptor (7)
- Protease-Activated Receptor (23)
- Retinoid X Receptor (13)
- Retinoic Acid Receptor (22)
- Prostanoid Receptor (24)
- Sphingosine-1-Phosphate Receptor (13)
- Platelet-Activating Factor (PAF) Receptor (5)
- Phosphodiesterase (34)
Products for Others - Page 3
- Cat.No. Product Name Information/Activity
-
BCC3794
Indomethacin
Indomethacin (Indometacin) is a potent and nonselective inhibitor of COX1 and COX2, with IC50s of 18 nM and 26 nM for human COX-1 and COX-2, respectively, in CHO cells.
-
BCC6490
Naproxen Sodium
Naproxen sodium is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively in cell assay.
-
BCC7944
NCX 4040
287118-97-2
-
BCC6219
NCX 466
1262956-64-8
-
BCC6857
NS 398
NS-398 is a non-steroidal an-inflammatory agent with analgesic and antipyretic effects, and selectively inhibits prostaglandin G/H synthase 2/cyclooxygenase 2 (COX-2) activity, with an IC50 of 3.8 μM, and has no effect on COX-1 at 100 μM.
-
BCC3841
Piroxicam
Piroxicam (CP-16171) is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC50s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively.
-
BCN5607
Resveratrol
Resveratrol (trans-Resveratrol; SRT501), a natural polyphenolic phytoalexin that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol (SRT 501) has a wide spectrum of targets including mTOR, JAK, β-amyloid, Adenylyl cyclase, IKKβ, DNA polymerase. Resveratrol also is a specific SIRT1 activator. Resveratrol is a potent pregnane X receptor (PXR) inhibitor.
-
BCC7111
SC 560
SC-560 is a potent and selective COX-1 inhibitor with an IC50 of 9 nM.
-
BCC5948
SC 58125
162054-19-5
-
BCC7809
SC 236
170569-86-5
